Anti-sclerostin antibodies for the treatment of osteoporosis

Research output: Contribution to journalArticle

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of anti-sclerostin antibodies for the treatment of osteoporosis.

Original languageEnglish (US)
Article numberCD012640
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number4
DOIs
StatePublished - Apr 21 2017

Fingerprint

Osteoporosis
Anti-Idiotypic Antibodies

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

@article{d65a00c9ca894263a0f7181f348fe5e6,
title = "Anti-sclerostin antibodies for the treatment of osteoporosis",
abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of anti-sclerostin antibodies for the treatment of osteoporosis.",
author = "Xerxes Pundole and Lopez-Olivo, {Maria Angeles} and Suarez-Almazor, {Maria E.} and Huifang Lu",
year = "2017",
month = "4",
day = "21",
doi = "10.1002/14651858.CD012640",
language = "English (US)",
volume = "2017",
journal = "The Cochrane database of systematic reviews",
issn = "1361-6137",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Anti-sclerostin antibodies for the treatment of osteoporosis

AU - Pundole, Xerxes

AU - Lopez-Olivo, Maria Angeles

AU - Suarez-Almazor, Maria E.

AU - Lu, Huifang

PY - 2017/4/21

Y1 - 2017/4/21

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of anti-sclerostin antibodies for the treatment of osteoporosis.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of anti-sclerostin antibodies for the treatment of osteoporosis.

UR - http://www.scopus.com/inward/record.url?scp=85018468693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018468693&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012640

DO - 10.1002/14651858.CD012640

M3 - Article

AN - SCOPUS:85018468693

VL - 2017

JO - The Cochrane database of systematic reviews

JF - The Cochrane database of systematic reviews

SN - 1361-6137

IS - 4

M1 - CD012640

ER -